20231229_艾瑞咨询_2023年中国女性私处护理白皮书（52页）.pdf

2023 iResearch Inc.20232 2023.12 iResearch I2023 x WHO 2008 40%2016 65%70%95%2021 70.6%64.4%x x 2023 30 164 1060 3 2023.12 iResearch I 2023 x 4 CONTENTS01 03 04 05 06 02 5 016 2023.12 iResearch I/7 2023.12 iResearch I 2016 10 2030 2021-2030 2016 10 2030 2021 9 2022 4 2021-2030 8 2023.12 iResearch I VS.2021-2022 923,1641,026,678860,000880,000900,000920,000940,000960,000980,0001,000,0001,020,0001,040,0002021 2022+11.2%3,808,775 5,716,630-1,000,000 2,000,000 3,000,000 4,000,000 5,000,000 6,000,000 7,000,0002021 2022+50.1%9 2023.12 iResearch I 2023.12 iResearch I13.7%14.2%16.4%18.4%19.1%0.0%5.0%10.0%15.0%20.0%25.0%658972458173 8138854500.20.40.60.811.22018 2019 2020 2021 2022-n=1060.Vs 2018+29.7%2023 2018-2022,50.9%,43.3%,5.8%,52.2%,42.1%,5.8%Vs 2018+5.4%2022 8545 2018 29.7%10 2023.12 iResearch I x/3D APP 11 2023.12 iResearch I 2018 2022 322.7 2027 484.9 10.4%x/210.9239.6271298.6322.7346.5373.3402.6439.1484.913.6%13.1%10.2%8.1%7.4%7.7%7.8%9.1%10.4%-190.0%-140.0%-90.0%-40.0%10.0%01002003004005006002018 2019 2020 2021 2022 2023e 2024e 2025e 2026e 2027e%2018-2027 12 0213 2023.12 iResearch I 2023.12 iResearch I,89.3%,10.7%-A5/n=1060/89.3%-A3/n=1060 2023 56.1%53.8%51.8%45.5%26.0%0.3%-5.0%5.0%15.0%25.0%35.0%45.0%55.0%65.0%/2023/89.3%78.5%64.9%40.2%21.3%0.1%0.0%20.0%40.0%60.0%80.0%100.0%14 2023.12 iResearch I 2023.12 iResearch I-A1 n=1060 91.3%59.3%4-A11 n=1060 2023,47.2%,44.2%,8.1%,0.4%,0.2%91.3%6 2023,6.2%,53.1%,16.0%,24.6%59.3%15 2023.12 iResearch I 2023.12 iResearch I-A8 n=1060 A9 n=1060 68.3%59.5%58.1%49.2%44.2%-n=10602023 2023 68.3%59.5%58.1%49.2%44.2%40.9%24.1%65.6%40.1%35.8%/26.6%78.2%37.1%16 2023.12 iResearch I 2023.12 iResearch I/,84.2%/,15.8%-A7 n=1060 84.2%5/-A13 n=1060 8 52023 2023 52.1%50.8%50.1%46.7%46.5%46.1%45.7%44.9%39.1%36.7%36.4%26.6%21.6%-5.0%5.0%15.0%25.0%35.0%45.0%55.0%65.0%/17 2023.12 iResearch I-A14 n=1060,21.0%,65.0%,8.5%,5.5%18-25 26-30 30 2023 18-25 26-30 31-35 36-40 41-45 113.3 87.6 88.1 85.7 114.8 103.8 105.2 101.1 87.1 88.9 58.8 80.0 124.7 174.1 151.8 69.1 114.5 92.7 194.5 94.5 30 30-40 40 2023-TGI 18 2023.12 iResearch I 2023.12 iResearch I,46.0%,48.7%,5.3%,0.0%-A16 n=1060 94.7%46%5-A15?n=1060 2023 2023,18.3%,53.8%,23.0%,4.9%94.7%19 2023.12 iResearch I 2023.12 iResearch I-A18/n=1060-A17/n=1060 2023 2023,31.4%,55.4%,8.6%,4.6%50.6%46.9%41.5%37.7%37.2%35.2%32.3%31.9%30.1%23.9%22.6%16.6%14.1%-5.0%5.0%15.0%25.0%35.0%45.0%55.0%65.0%/B/B 20 0321 2023.12 iResearch I 4.9%6.9%14.6%26.9%7.9%7.8%7.2%6.7%6.5%10.2%0.0%5.0%10.0%15.0%20.0%25.0%30.0%35.0%/-n=554 26.2%23.3%25.8%13.7%11.0%0.0%5.0%10.0%15.0%20.0%25.0%30.0%35.0%40.0%45.0%50.0%18-25 26-30 31-35 36-40 41-45 28.5%27.8%26.7%17.0%0.0%5.0%10.0%15.0%20.0%25.0%30.0%35.0%40.0%45.0%50.0%5.4%8.8%19.0%28.2%26.0%8.1%4.5%0.0%5.0%10.0%15.0%20.0%25.0%30.0%35.0%40.0%45.0%50.0%3000 3,001 5,000 5,001 8,000 8,001 10,000 10,001 15,000 15,001 20,000 20,000 4.9%16.4%73.6%5.0%0.0%20.0%40.0%60.0%80.0%100.0%120.0%18-35,12.6%,15.7%,8.3%,62.3%,1.1%8000 TGI:116.5TGI:125.0TGI:139.7TGI:145.2TGI:140.0TGI:106.2TGI:108.1TGI:104.7TGI:106.6TGI:101.8TGI:102.0TGI:117.8TGI:106.9 22 2023.12 iResearch I 2023.12 iResearch I-A2 n=1060-A3/n=1060 89.3%94.0%84.2%39.4%29.8%51.2%/78.9 83.5 74.0 75.7 23 2023.12 iResearch I 2023.12 iResearch I-S9 n=554-S8 n=554 Top TGI108.8 103.3 101.1 107.1 108.1 3.2%23.8%39.5%22.4%10.3%0.7%-5.0%5.0%15.0%25.0%35.0%45.0%55.0%1 1-2 3-4 5-6 6 TGI:105.6TGI:116.1TGI:115.761.2%31.6%6.0%1.3%0.0%0.0%10.0%20.0%30.0%40.0%50.0%60.0%70.0%80.0%90.0%100.0%TGI:106.6 TGI:101.285.2%24 2023.12 iResearch I 2023.12 iResearch I-B2 n=554 18-30 18-25/-B1 B3 n=554 18-30 7.0%48.0%31.0%9.0%2.3%2.5%-5.0%5.0%15.0%25.0%35.0%45.0%55.0%65.0%18 18-25 26-30 31-35 36-40 41-45 49.8%33.8%47.5%33.5%&/56.1%47.8%25 2023.12 iResearch I18-25 26-30 31-35 36-40 41-45 109.2 119.9 94.3 87.6 64.9 70.6 83.6 125.3 115.5 125.9 107.9 118.3 88.3 81.8 92.7 87.1 93.9 126.1 91.5 92.9 71.6 111.8 117.0 113.9 85.1 71.9 138.9 98.0 107.2 80.1 30 30 2.7 30 30-B4 n=544 30 30-40 40 55.6%54.7%53.1%38.8%34.7%30.7%0.0%10.0%20.0%30.0%40.0%50.0%60.0%70.0%80.0%-/-2023 2023-TGI 2.7 26 2023.12 iResearch I 2023.12 iResearch I-B7 n=554 92.4%-B5 n=554/2023 2023 1,6.7%1,27.3%4-6,31.2%1-3,27.3%1,7.6%65.0%55.1%51.4%44.8%37.0%30.5%27.8%17.5%-5.0%5.0%15.0%25.0%35.0%45.0%55.0%65.0%75.0%/92.4%27 2023.12 iResearch I-B9 n=554 2023 64.4%56.1%52.7%39.2%32.7%42.8%31.6%93.0%28 2023.12 iResearch I 2023.12 iResearch I-C3 n=544 2-3 4.7 200-500 342.7-C1 n=554 4.7 342.7 2023 2023 17.0%39.9%22.7%14.3%6.1%-5.0%5.0%15.0%25.0%35.0%45.0%55.0%65.0%1 1 1 1 1 4.7 342.7 19.8%27.3%32.0%20.9%-5.0%5.0%15.0%25.0%35.0%45.0%55.0%65.0%200 200-300 300-500 500 29 2023.12 iResearch I TOP3-n=554 2023 60.6%50.4%47.8%44.9%32.3%24.5%29.4%17.0%17.0%34.3%24.4%36.3%29.8%0.0%10.0%20.0%30.0%40.0%50.0%60.0%70.0%/KOL 57.0%53.2%52.1%34.7%32.5%9.8%0.0%10.0%20.0%30.0%40.0%50.0%60.0%70.0%80.0%51.1%48.9%32.4%64.0%3.7%30 2023.12 iResearch I 2023.12 iResearch I-C12 n=554-C10 n=554/72.2%41.7%38.1%28.5%20.8%19.7%9.2%9.2%55.2%54.7%45.8%23.3%6.7%0.0%20.0%40.0%60.0%80.0%100.0%O2O/44.4%43.0%36.5%34.3%33.6%31.8%28.7%23.3%15.5%50.5%39.0%28.9%0.0%10.0%20.0%30.0%40.0%50.0%60.0%70.0%B/31 0432 2023.12 iResearch I x pH 3.5-5 pH 3.8-4.5Ph 3.5-5-33 2023.12 iResearch I x 01 02 03 04 06 05 34 2023.12 iResearch I/35 2023.12 iResearch I x 1 36 2023.12 iResearch I x 30-40 3 1 2-3 1-2 pH 2 37 2023.12 iResearch I x 3 01 02 pH pH 38 2023.12 iResearch I pH pH 3.5-5 x pH pH 1pH 3.5-5 2 3 pH 4 39 0540 2023.12 iResearch I/25-50 25-70 75-100 45-75 25-70-x 41 2023.12 iResearch I SWEMISS x Slogan SWEMISS SWEMISS 1 2 3 4 SWEMISS 42 2023.12 iResearch I x SWEMISS 01 02 03 9 0 1 2+9+04 43 2023.12 iResearch I SWEMISS x SWEMISS|ZL 2013 1 0597323.9 9 0+VS pH pH 0 MISS-BALANCE 44 2023.12 iResearch I SWEMISS x Relipidium+MISS-BALANCE+100%Corbions PURAC L+100%PH 3.55 PH 9 0 0 0 0 0 0 0 0 0 0 0+45 0646 2023.12 iResearch I/1/2 x 40.1%33.8%47 2023.12 iResearch I 2/2 x 1 2 3 4 pH pH3.5-5 83.5 74.0 75.7 83.5 74.6%68.9%48 2023.12 iResearch I x 01 02 01 02 49 2023.12 iResearch I2023 x x x 3 2 1 4 50 BUSINESS COOPERATION400-026-51 LEGAL STATEMENT THANKS